IP Library Granted Patent US 12,686,685
Granted Patent B2
US 12,686,685 · App. 18/006,199 · Granted Jul 21, 2026

Method for large-scale synthesis of tetrodotoxin

Inventors: Guangyin Wang (Shanghai, CN); Xiaoming Li (Shanghai, CN); Chengxi Wang (Shanghai, CN); Ping Huang (Shanghai, CN); Hua Bai (Shanghai, CN); Liang Lai (Shanghai, CN); Peng Guo (Shanghai, CN); Biao Jiang (Shanghai, CN); Wenfeng Zhu (Shanghai, CN)
Assignees: Shanghai Shengping Medical Equipment Co., Ltd.; VastPro (Zhejiang) Pharmaceutical Co., Ltd.; Zhejiang Boxiao Biopharmaceutical Co., Ltd.
C07D491/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,686,685
App. No.
18/006,199
Filed
Jan 20, 2023
Granted
Jul 21, 2026
Kind
B2
Art Unit
1621
USPC
546/63
Abstract

The present invention provides a method for biological and chemical synthesis of tetrodotoxin, specifically comprising the following steps: using cheap and easily available benzyl acetate as a raw material, and performing biological fermentation to obtain an optically pure intermediate ((5S, 6R)-5, 6-dihydroxycyclohexa-1, 3-dienyl) methyl acetate (formula I); and performing a series of chemical conversions on the intermediate to finally obtain tetrodotoxin at a purity of 95% or more without purifying the product. The present invention has the potential of large-scale production, and is an excellent alternative to the existing extraction method from a pufferfish.

Claims (35)

1 . A method for preparing tetrodotoxin represented by formula TTX, comprising:

(1) subjecting a compound of formula II to an intramolecular cyclization with a base in a solvent to obtain a compound of formula III:

wherein R is C 1-6 alkyl or substituted alkyl, and the base is selected from the group consisting of potassium carbonate, sodium carbonate, potassium bicarbonate and sodium bicarbonate; and the solvent is selected from the group consisting of methanol, ethanol and toluene;

(2) removing Boc protecting group from the compound of formula III to obtain a compound of formula IV:

(3) reacting the compound of formula IV with Cbz methylthiourea to obtain a compound of formula V:

wherein, a metal Lewis acid is used in the reaction;

(4) subjecting the compound of formula V to a molecular cyclization to obtain a compound of formula VI-a and a compound of formula VI-b:

wherein, the compound of formula VI-a and the compound of formula VI-b are separated by a chiral preparative HPLC;

(5) hydrolyzing the compound of formula VI-b to obtain the compound of formula VI-a:

wherein, the compound of formula VI-a and the compound of formula VI-b are separated by a chiral preparative HPLC; and

(6) hydrogenating the compound of formula VI-a in a solvent to remove the protecting group Cbz, and then obtaining the tetrodotoxin after filtration and concentration,

wherein, Cbz represents benzyloxycarbonyl, and the solvent is selected from the group consisting of methanol, ethanol, ethyl acetate and isopropanol.

2 . The method for preparing tetrodotoxin according to claim 1 , further comprising using an aqueous mixed fiber microporous filter membrane for the filtration.

3 . The method for preparing tetrodotoxin according to claim 1 , wherein, the molecular cyclization in step (4) is carried out with an acid.

4 . The method for preparing tetrodotoxin according to claim 3 , wherein, the reaction in step (5) is carried out with an acid.

5 . The method for preparing tetrodotoxin according to claim 1 , wherein, the metal Lewis acid in step (3) is copper chloride.

6 . The method for preparing tetrodotoxin according to claim 5 ,

wherein, in the step (2) reaction, acetonitrile is used as a solvent, trimethyliodosilane is used as a reagent, and the reaction temperature is from −10° C. to 50° C.

7 . The method for preparing tetrodotoxin according to claim 6 , wherein, the reaction temperature is 0° C.

8 . The method for preparing tetrodotoxin according to claim 1 , wherein, in step (1), the base is potassium carbonate and the solvent is methanol.

9 . A method for preparing tetrodotoxin, comprising the following steps:

(1) subjecting a compound of formula II to an intramolecular cyclization with a base in a solvent to obtain a compound of formula III;

wherein R is C 1-6 alkyl or substituted alkyl, and the base is selected from the group consisting of potassium carbonate, sodium carbonate, potassium bicarbonate and sodium bicarbonate; and the solvent is selected from the group consisting of methanol, ethanol and toluene;

(2) removing Boc protecting group from the compound of formula III to obtain a compound of formula IV:

wherein, acetonitrile is used as a solvent, trimethyliodosilane is used as a reagent, and the reaction temperature is from −10° C. to 50° C.;

(3) reacting the compound of formula IV with Cbz methylthiourea to obtain a compound of formula V

wherein, a metal Lewis acid is used in the reaction;

(4) subjecting the compound of formula V to a molecular cyclization to obtain a compound of formula VI-a and a compound of formula VI-b

wherein, the compound of formula VI-a and the compound of formula VI-b are separated by a chiral preparative HPLC;

(5) hydrolyzing the compound of formula VI-b to obtain the compound of formula VI-a

wherein, the compound of formula VI-a and the compound of formula VI-b are separated by a chiral preparative HPLC; and

(6) subjecting the compound of formula VI-a to hydrogenation in a solvent to remove Cbz protecting group to obtain a compound of formula TTX after filtration

wherein, Cbz represents benzyloxycarbonyl, and the solvent is selected from the group consisting of methanol, ethanol, ethyl acetate and isopropanol; and an aqueous mixed fiber microporous filter membrane is used for the filtration.

10 . The method for preparing tetrodotoxin according to claim 1 , wherein, the metal Lewis acid is selected from the group consisting of lead chloride, lead acetate, silver nitrate, copper chloride and cuprous chloride.

11 . The method for preparing tetrodotoxin according to claim 9 , wherein, the metal Lewis acid is selected from the group consisting of lead chloride, lead acetate, silver nitrate, copper chloride and cuprous chloride.

Assignments (2)
CHANGE OF NAME Recorded May 26, 2026
From: SHANGHAI VASTPRO TECHNOLOGY DEVELOPMENT CO., LTD.
To: VASTPRO (ZHEJIANG) PHARMACEUTICAL CO., LTD.
Reel/Frame 075641/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2023
From: WANG, GUANGYIN; LI, XIAOMING; WANG, CHENGXI; HUANG, PING; BAI, HUA; LAI, LIANG; GUO, PENG; JIANG, BIAO; ZHU, WENFENG
To: SHANGHAI SHENGPING MEDICAL EQUIPMENT CO., LTD.; SHANGHAI VASTPRO TECHNOLOGY DEVELOPMENT CO., LTD.; ZHEJIANG BOXIAO BIOPHARMACEUTICAL CO., LTD.
Reel/Frame 062928/0009 →
Priority Claims (1)
CN 202010699434.0 · Jul 20, 2020 · national
Continuity (1)
Related Publication 20230312596A1 · Oct 5, 2023
References Cited (21)
US 20080145303A1 · Hirota · 2008 [cited by applicant]
US 20150190781A1 · Hanamoto · 2015 [cited by applicant]
CN 101111454A · 2008 [cited by applicant]
CN 107641128A · 2018 [cited by applicant]
WO 2006080202A1 · 2006 [cited by applicant]
WO 2013191269A1 · 2016 [cited by applicant]
Kaestle, “Cleavage of Esters Using Carbonates and Bicarbonates of Alkali Metals: Synthesis of Thymopentin” Tetrahedron Letters, 1991, pp. 327-330. [cited by examiner]
Katritzky, A. R.; Rogovoy, B.V. Arkivoc 2005, (iv) 49-87. [cited by examiner]
Ohyabu Journal of the American Chemical Society, 2003, 125(29), 8798-8805. [cited by examiner]
R. Sahai “Membrane Filtration” in Encyclopedia of Separation Science, 2000, p. 1717-1724. [cited by examiner]
Brandt et al. “Practical Aspects of Preparative HPLC in Pharmaceutical and Development Production” LC⋅GC Europe Mar. 2-5, 2002. [cited by examiner]
Maehara, Tomoaki; “Total Synthesis of (-)-Tetrodotoxin and 11-norTTX-6(R)-ol.” Angewandte Chemie, International Edition, 56(6), 1549-1552 2017. [cited by examiner]
Hawach Scientific, Shaanxi Province, P.R. China, Filter membrane page Online: “https://www.hawachmembrane.com/membranes-filters-mce-reg-cellulose-pes-and-ptfe/” accessed Feb. 26, 2026. [cited by examiner]
International Search Report issued Oct. 20, 2021 in PCT/CN2021/107076. [cited by applicant]
Tomoaki Maehara, et al., “Total Synthesis of (-)-Tetrodotoxin and 11-norTTX-6(R)-ol,” Angewandte Chemie, vol. 129, No. 6, pp. 24-29, Dec. 31, 2017. [cited by applicant]
Norio Ohyabu, et al., “First Asymmetric Total Synthesis of Tetrodotoxin,” J.Am. Chem. Soc., vol. 29, No. 125, pp. 3798-8799, Jun. 28, 2003. [cited by applicant]
Wu, Wutong, “(non-official translation: Section 3, Microporous Membrane Filtration Technology),” (non-official translation: Biopharmaceutical Technology), pp. 324-326, Dec. 31, 2015. [cited by applicant]
Wang, Xiangyu, “(non-official translation: 5.4.1 Selection of Cellulose-Modified Iron Nanoparticles Removal Dye Types),” (non-official translation: Zero-Valent Molten Iron Nanoparticle Processing Technology in Environme… [cited by applicant]
Written Opinion issued Oct. 20, 2021 in PCT/CN2021/107076. [cited by applicant]
Protective Groups in Organic Synthesis, 3rd Ed. pp 415-417 (1999). [cited by applicant]
Tomoaki Maehara, et al, “Total Synthesis of (-)- Tetrodotoxin and 11-norTTX-6(R)-ol,” Agnew Chem, V. 129, pp. 1571-1574 (2017). [cited by applicant]